Wednesday, August 5, 2026
NewsWhite
BUSINESS

Novo Nordisk's raised forecast fails to change the debate over its obesity business

Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.

Read More →

Latest News

Most Read

Technology

See All →

Politics

See All →

Business

See All →